Measure | Target | T0 | Intervention | T1 |
---|---|---|---|---|
 |  | Baseline | Morning and evening treatment (4 recordings/day) | Post-intervention (2 weeks) |
NRS | Average pain intensity | X | Â | X |
NRS | Current pain intensity | X | X | X |
HRV | Hear rate variability | X | X | X |
BMI and WHR | Body mass index and waist-to-hip ratio | X | Â | Â |
BP | Blood pressure | X | Â | X |
CPA | Experimental pain threshold, tolerance, and limit | X | Â | X |
CEQ | Treatment efficacy expectation | X | Â | Â |
PGIC | Treatment efficacy impression | Â | Â | X |
EQ-5D-5L | Health-related quality of life | X | Â | X |
HSCL-25 | Stress and depression | X | Â | X |
MAIA-2 | Interoceptive awareness | X | Â | X |
SpREUK-15 | Spirituality | X | Â | X |
PCS | Catastrophizing | X | Â | X |
BPI | Pain interference | X | Â | X |
ISI | Insomnia | X | Â | X |
ODI | Functional disability | X | Â | X |
General health | Overall health/nutrition and sociodemographic | X | Â | Â |